Naomichi Koga
Overview
Explore the profile of Naomichi Koga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sugiyama M, Kasagi Y, Yokomizo R, Terashi M, Oonishi E, Nagai T, et al.
Anticancer Res
. 2025 Mar;
45(3):1233-1239.
PMID: 40037848
Background/aim: Locally advanced rectal cancer (LARC) with adjacent organ invasion presents significant surgical challenges, particularly in achieving negative circumferential resection margins (CRM). Transanal total mesorectal excision (TaTME) offers improved visualization...
2.
Prognostic impact of osteosarcopenia on postoperative outcomes in patients with biliary tract cancer
Shimagaki T, Sugimachi K, Tomino T, Onishi E, Koga N, Kasagi Y, et al.
Surg Today
. 2024 Dec;
PMID: 39625483
Purpose: Frailty, characterized by sarcopenia and osteopenia, is associated with poor survival after the resection of biliary tract cancer (BTC). Osteosarcopenia, the coexistence of sarcopenia and osteopenia, has recently been...
3.
Sugiyama M, Nishijima T, Kasagi Y, Uehara H, Yoshida D, Nagai T, et al.
J Surg Oncol
. 2024 Jun;
130(2):329-337.
PMID: 38881197
Background And Objectives: This study aimed to assess the effectiveness of Comprehensive Geriatric Assessment (CGA) in customizing care for elderly cancer patients, specifically focusing on colorectal cancer. The research compared...
4.
Nakanishi R, Morooka K, Omori K, Toyota S, Tanaka Y, Hasuda H, et al.
Ann Surg Oncol
. 2022 Dec;
30(6):3506-3514.
PMID: 36512260
Background: To develop an artificial intelligence-based model to predict recurrence after curative resection for stage I-III colorectal cancer from digitized pathological slides. Patients And Methods: In this retrospective study, 471...
5.
Koga N, Hu Q, Sakai A, Takada K, Nakanishi R, Hisamatsu Y, et al.
Cancer Sci
. 2021 May;
112(8):3018-3028.
PMID: 34009732
Signal regulatory protein alpha (SIRPα) is a type I transmembrane protein that inhibits macrophage phagocytosis of tumor cells upon interaction with CD47, and the CD47-SIRPα pathway acts as an immune...
6.
Nakanishi R, Oki E, Hasuda H, Sano E, Miyashita Y, Sakai A, et al.
Ann Surg Oncol
. 2021 Mar;
28(6):2986-2987.
PMID: 33725205
No abstract available.
7.
Nakanishi R, Oki E, Hasuda H, Sano E, Miyashita Y, Sakai A, et al.
Ann Surg Oncol
. 2021 Jan;
28(6):2975-2985.
PMID: 33454878
Objective: The aim of this study was to develop a radiomics-based prediction model for the response of colorectal liver metastases to oxaliplatin-based chemotherapy. Methods: Forty-two consecutive patients treated with oxaliplatin-based...
8.
Koga N, Kubo N, Saeki H, Sasaki S, Jogo T, Hirose K, et al.
Surg Case Rep
. 2019 Jan;
5(1):4.
PMID: 30635729
Background: Primary amelanotic malignant melanoma of esophagus, which is a subtype of primary malignant melanoma of the esophagus (PMME), is a very rare disease with a poor prognosis. We herein...